What is the HEART score and how is it used in the emergency department to exclude acute coronary syndrome in patients with chest pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HEART Score for Excluding ACS in the Emergency Department

The HEART score is a validated 5-component risk stratification tool (History, ECG, Age, Risk factors, Troponin) that safely identifies low-risk chest pain patients (score 0-3) who can be discharged from the ED with less than 2% risk of 30-day major adverse cardiac events (MACE), outperforming older tools like TIMI and GRACE scores. 1, 2, 3, 4

Components and Scoring System

The HEART score assigns 0-2 points for each of five components, creating a total score range of 0-10 2, 5:

  • History: Highly suspicious presentations (exertional chest pain relieved by rest, associated symptoms like orthopnea, nausea, or "indigestion") receive 2 points; moderately suspicious receive 1 point; non-suspicious receive 0 points 2, 6

  • ECG: Significant ST-segment depression receives 2 points; nonspecific repolarization abnormalities receive 1 point; completely normal ECG receives 0 points 2, 5

  • Age: Patients ≥65 years receive 2 points; age 45-64 receives 1 point; <45 years receives 0 points 2

  • Risk factors: Three or more traditional cardiovascular risk factors (hypertension, hyperlipidemia, diabetes, smoking, family history, obesity) receive 2 points; 1-2 risk factors receive 1 point; none receive 0 points 2, 5

  • Troponin: Levels >3× the upper limit of normal receive 2 points; 1-3× normal receive 1 point; normal receives 0 points 2

Risk Stratification Categories

The American College of Cardiology recommends three distinct risk categories 2, 5:

  • Low risk (0-3 points): <1-2% risk of 30-day MACE, supporting immediate discharge without further cardiac testing 2, 3, 4

  • Intermediate risk (4-6 points): 16.6% risk of MACE, requiring observation with serial troponins or stress testing 4

  • High risk (7-10 points): 50-65% risk of MACE within 6 weeks, mandating immediate admission with cardiology consultation and likely cardiac catheterization 6, 4

Integration with High-Sensitivity Troponin Protocols

The American Heart Association recommends combining the HEART score with serial high-sensitivity troponin measurements at 0 and 2 hours for optimal risk stratification 2, 5. When both measurements are below the 99th percentile with a HEART score of 0-3, the false negative rate drops to 0.8-0.9% for 30-day MACE 1. This accelerated diagnostic protocol safely decreases hospital admissions while maintaining acceptable miss rates of 1-2% 2.

Performance Compared to Other Risk Scores

The HEART score demonstrates superior discrimination compared to historical tools 1, 3, 4:

  • C-statistic of 0.83 versus TIMI (0.75) and GRACE (0.70), with statistically significant superiority (p<0.0001) 3, 4

  • The American College of Radiology notes that older scores like TIMI, GRACE, and PURSUIT are being replaced by the HEART score, which was specifically designed for ED chest pain evaluation without a diagnosis of ACS 1

  • International consensus guidelines from 2010 explicitly state that scoring systems derived from in-patient populations (TIMI, Goldman Criteria) are not appropriate for ED use and should not be used to select patients for safe discharge 1

Critical Implementation Pitfalls

Serial ECG monitoring is crucial when the initial ECG is nondiagnostic, as dynamic changes may emerge that alter risk stratification 2, 5. The HEART score may be less accurate in very early presenters (within 2-3 hours of symptom onset) where troponin elevation hasn't yet occurred 2.

A 2021 prospective study found only moderate agreement (78%, kappa 0.48) between clinician-generated and research-generated HEART scores, with the lowest agreement in the History (72%) and ECG (85%) components 7. This highlights the subjective nature of certain components and the need for standardized interpretation.

Do not attribute troponin elevation solely to demand ischemia or hypertensive emergency without excluding Type 1 MI through coronary angiography, particularly when troponin shows a rising pattern 6. Patients with exertional patterns, rising troponin, and ECG changes require revascularization evaluation regardless of blood pressure 6.

Clinical Application Algorithm

For patients presenting with chest pain 2, 5, 6:

  1. Calculate HEART score immediately after obtaining initial ECG and troponin results

  2. Score 0-3: Discharge home with outpatient cardiology follow-up if needed; no further inpatient cardiac testing required

  3. Score 4-6: Admit for observation with repeat troponin at 2-3 hours, or proceed to stress imaging (PET/SPECT, CMR, or stress echocardiography) for known CAD patients

  4. Score 7-10: Immediate hospital admission with cardiology consultation; proceed to invasive coronary angiography

  5. Borderline scores (3-4): Use shared decision-making and consider repeat troponin measurement before final disposition

The American College of Emergency Physicians endorses achieving a miss rate of 1-2% for 30-day MACE, which the HEART score reliably achieves when properly applied 2. However, avoid overreliance on a single parameter while ignoring clinical context 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Decision-Making in Chest Pain using the HEART Score

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk Stratification of Admitted Patients with Chest Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HEART Score Calculation and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What scoring criteria can be used to aid in assessing admitted patients with chest pain?
What is the role of the HEART (History, Electrocardiogram, Age, Risk factors, and Troponin) score in assessing patients with acute chest pain?
What is the controversy surrounding the reliability of the HEART (History, Electrocardiogram, Age, Risk factors, and Troponin) score?
What is the purpose of the HEART (History, Electrocardiogram, Age, Risk factors, Troponin) score and when should it be applied?
What is the Heart Score and what is its purpose?
What oral antibiotic alternatives are appropriate for acute pyelonephritis in a patient who cannot take cefpodoxime?
What is the recommended diagnostic work‑up and initial management for an adult patient with unilateral head pain that originates in the neck, worsens with neck movement or sustained posture, is reproduced by cervical palpation, and lacks migraine or tension‑type features, assuming no red‑flag signs?
At 13‑17 weeks gestation I experience nightly pain lasting about 30 minutes; what is the likely cause and appropriate management?
How should I manage an elderly patient (≥65 years) with an isolated TSH of 9 mIU/L?
In an asymptomatic, non‑high‑risk patient (no pregnancy, recent urologic instrumentation, immunocompromise, or catheterization), should antimicrobial therapy be stopped if the urine culture shows fewer than 10,000 colony‑forming units per milliliter?
What is the recommended management for a patient with mild atherosclerotic vascular disease, such as early peripheral arterial disease, asymptomatic carotid plaque, or subclinical coronary disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.